Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 133Thoracic 21Breast 14Sarcoma 11Genitourinary 8Dermatologic 5Gastrointestinal 4Gynecologic 3Endocrine 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Head & Neck 1Classical hematology 1

Conditions

Anemia 64Neoplasms 38Venous Thromboembolism 29Leukemia 21Anemia, Refractory, with Excess of Blasts 20Myelodysplastic Syndromes 19Lymphoma 14Thrombocytopenia 13Multiple Myeloma 12Leukemia, Myelomonocytic, Chronic 12Venous Thrombosis 11Pulmonary Embolism 11Febrile Neutropenia 11Breast Neoplasms 10Myeloproliferative Disorders 9Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 9Neoplasms, Plasma Cell 8Lymphoma, Follicular 8Leukemia, Myeloid, Acute 8Primary Myelofibrosis 6Neutropenia 6Hodgkin Disease 6Hemophilia A 6Lung Neoplasms 5Anemia, Refractory 5Waldenstrom Macroglobulinemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precancerous Conditions 4Lymphoproliferative Disorders 4

Interventions

Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Brain Neoplasms × Classical hematology × Clear all
NCT00135876 2007-04-27

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Ontario Clinical Oncology Group (OCOG)

Phase 3 Completed
512 enrolled
CNSClassical hematology

Brain Neoplasms, Glioma, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡